Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: Results of a multicenter retrospective Italian study

Gynecologic Oncology

Volumn 98, Issue 1, 2005, Pages 118-123

  Gadducci, Angiolo ^a   Sartori, Enrico ^b   Landoni, Fabio ^c   Zola, Paolo ^d   Maggino, Tiziano ^e   Colombo, Nicoletta ^c   Fanucchi, Antonio ^a   Chiudinelli, Francesca ^b   LaPresa, Mariateresa ^c   Ferrero, Anna Maria ^d  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anemia; Carboplatin; Chemotherapy; Cisplatin; Hemoglobin; Ovarian cancer; Paclitaxel

Indexed keywords

CARBOPLATIN; CISPLATIN; IFOSFAMIDE; PACLITAXEL; PLATINUM; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOMES RESEARCH; OVARY CANCER; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; EPITHELIAL CELLS; FEMALE; HEMOGLOBINS; HUMANS; IFOSFAMIDE; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; PROGNOSIS; RETROSPECTIVE STUDIES; TAXOIDS;

EID: 20444445808     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.04.012     Document Type: Article

References (57)

1. J.L. Spivak Cancer-related anemia: its causes and characteristics Semin. Oncol. 21 Suppl 3 1994 3 8
2. A.R. Moliterno, and J.L. Spivak Anemia of cancer Hematol. Oncol. Clin. North Am. 10 1996 345 363
3. S. Mercadante, V. Gebbia, A. Marrazzo, and S. Filosto Anaemia in cancer: pathophysiology and treatment Cancer Treat. Rev. 26 2000 303 311
4. D. Bron, N. Meuleman, and C. Mascaux Biological basis of anemia Semin. Oncol. 28 2001 1 6
5. F. Tas, Y. Eralp, M. Basaran, B. Sakar, S. Alici, and A. Argon Anemia in oncology practice: relation to diseases and their therapies Am. J. Clin. Oncol. 25 2002 371 379
6. G. Auclerc, J.B. Meric, A. Pommeyrol, O. Rixe, and D. Khayat Anemia in cancer patients before treatment Bull. Cancer 90 2003 S128 S132
7. M. Dicato Anemia in cancer: some pathophysiological aspects Oncologist 8 Suppl 1 2003 19 21
8. D.H. Henry III, and N. Thatcher Patient selection and predicting response to recombinant human erythropoietin in anemic cancer patients Semin. Hematol. 33 Suppl 1 1996 2 5
9. N.S. Tchekmedyian Anemia in cancer patients: significance, epidemiology, and current therapy Oncology 16 Suppl 10 2002 17 24
10. M. Lind, C. Vernon, D. Cruickshank, P. Wilkinson, T. Littlewood, and N. Stuart The level of haemoglobin in anaemic cancer patients correlates positively with quality of life Br. J. Cancer 86 2002 1243 1249
11. V. Mock, and M. Olsen Current management of fatigue and anemia in patients with cancer Semin. Oncol. Nurs. 19 Suppl 2 2003 36 41
12. S.D. Ross, K. Fahrbach, D. Frame, R. Scheye, J.E. Connelly, and J. Glaspy The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review Clin. Ther. 25 2003 1786 1805
13. S.D. Young, R.S. Marshall, and R.P. Hill Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells Proc. Natl. Acad. Sci. U. S. A. 85 1988 9533 9537
14. D. Gonzalez Gonzalez Hypoxia and local tumour control: Part 1 Radiother. Oncol. 20 Suppl 1 1991 5 7
15. M. Hockel, K. Schlenger, B. Aral, M. Mitze, U. Schaffer, and P. Vaupel Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res. 56 1996 4509 4515
16. B.C. Liang Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines J. Neurooncol. 29 1996 149 155
17. T.Y. Reynolds, S. Rockwell, and P.M. Glazer Genetic instability induced by the tumor microenvironment Cancer Res. 56 1996 5754 5757
18. M. Hockel, and P. Vaupel Biological consequences of tumor hypoxia Semin. Oncol. 28 2001 36 41
19. F.K. Reiher, M. Ivanovich, H. Huang, N.D. Smith, N.P. Bouck, and S.C. Campbell The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer J. Urol. 165 2001 2075 2081
20. T.G. Graeber, C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, and S.W. Lowe Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 1996 88 91
21. S.J. Van Belle, and V. Cocquyt Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy Crit. Rev. Oncol. Hematol. 47 2003 1 11
22. P. Vaupel, A. Mayer, S. Briest, and M. Hockel Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers Cancer Res. 63 2003 7634 7637
23. J. Dunst, S. Pigorsch, G. Hansgen, I. Hintner, C. Lautenschlager, and A. Becker Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis? Strahlenther. Onkol. 175 1999 93 96
24. I. Moullet, G. Salles, N. Ketterer, C. Dumontet, F. Bouafia, and E.M. Neidhart-Berard Frequency and significance of anemia in non-Hodgkin's lymphoma patients Ann. Oncol. 9 1998 1109 1115
25. H. Samaha, C. Dumontet, N. Ketterer, I. Moullet, C. Thieblemont, and F. Bouafia Mantle cell lymphoma: a retrospective study of 121 cases Leukemia 12 1998 1281 1287
26. D. Hasenclever, and V. Diehl A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease N. Engl. J. Med. 339 1998 1506 1514
27. M. Federico, U. Vitolo, P.L. Zinzani, T. Chisesi, V. Clo, and G. Bellesi Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi Blood 95 2000 783 789
28. J. Landman-Parker, H. Pacquement, T. Leblanc, J.L. Habrand, M.J. Terrier-Lacombe, and Y. Bertrand Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90 J. Clin. Oncol. 18 2000 1500 1507
29. W. Kern, C. Schoch, T. Haferlach, J. Braess, M. Unterhalt, and B. Wormann Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities Leukemia 14 2000 226 231
30. T. Girinski, M.H. Pejovic-Lenfant, J. Bourhis, F. Campana, J.M. Cosset, and C. Petit Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients Int. J. Radiat. Oncol. Biol. Phys. 16 1989 37 42
31. K.S. Albain, J.J. Crowley, M. LeBlanc, and R.B. Livingston Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience J. Clin. Oncol. 9 1991 1618 1626
32. J.H. Hong, M.S. Chen, F.J. Lin, and S.G. Tang Prognostic assessment of tumor regression after external irradiation for cervical cancer Int. J. Radiat. Oncol. Biol. Phys. 22 1992 913 917
33. R.J. Motzer, M. Mazumdar, J. Bacik, W. Berg, A. Amsterdam, and J. Ferrara Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma J. Clin. Oncol. 17 1999 2530 2540
34. L. Sengelov, C. Kamby, P. Geertsen, L.J. Andersen, and H. von der Maase Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer Cancer Chemother. Pharmacol. 46 2000 357 364
35. L. Sengelov, C. Kamby, G. Schou, and H. von der Maase Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract Cancer 74 1994 123 133
36. G.R. Jatzko, P.H. Lisborg, H. Denk, M. Klimpfinger, and H.M. Stettner A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan Cancer 76 1995 1302 1312
37. D.A. Fein, W.R. Lee, A.L. Hanlon, J.A. Ridge, C.J. Langer, and W.J. Curran Jr. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx J. Clin. Oncol. 13 1995 2077 2083
38. W.R. Lee, B. Berkey, V. Marcial, K.K. Fu, J.S. Cooper, and B. Vikram Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27 Int. J. Radiat. Oncol. Biol. Phys. 42 1988 1069 1075
39. M. Grogan, G.M. Thomas, I. Melamed, F.L. Wong, R.G. Pearcey, and P.K. Joseph The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix Cancer 86 1999 1528 1536
40. S. Ylisirnio, M.L. Sassi, J. Risteli, T. Turpeenniemi-Hujanen, and A. Jukkola Serum type I collagen degradation markers, ICTP and CrossLaps are factors for poor survival in lung cancer Anticancer Res. 19 1999 5577 5581
41. T.J. Robnett, M. Machtay, S.M. Hahn, J.B. Shrager, J.S. Friedberg, and L.R. Kaiser Pathological response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients Cancer J. 8 2002 263 267
42. E.I. Cho, C.T. Sasaki, and B.G. Haffty Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 58 2004 1135 1140
43. G. Macdonald, and D.C. Hurman Influence of anaemia in patients with head and neck cancer receiving adjuvant postoperative radiotherapy in the Grampian region Clin. Oncol. (R. Coll. Radiol.). 16 2004 63 70
44. E.A. Eisenhauer, J.B. Vermorken, and M. van Glabbeke Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients Ann. Oncol. 8 1997 963 968
45. A. Obermair, A. Handisurya, A. Kaider, P. Sevelda, H. Kolbl, and G. Gitsch The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients Cancer 83 1998 726 731
46. A. Obermair, E. Petru, G. Windbichler, C. Peters-Engl, A.H. Graf, and W. Stummvoll Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer Oncol. Rep. 7 2000 639 644
47. T. Safra, S. Groshen, S. Jeffers, D.D. Tsao-Wei, L. Zhou, and L. Muderspach Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome Cancer 91 2001 90 100
48. K. Munstedt, M. Kovacic, M. Zygmunt, and R. Von Georgi Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer Int. J. Oncol. 23 2003 837 843
49. A. Nather, K. Mayerhofer, C. Grimm, L. Hefler, S. Leodolter, and A. Obermair Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy Anticancer Res. 23 2003 2991 2994
50. A. Gadducci, S. Cosio, A. Fanucchi, L. Tanganelli, P.F. Conte, and R. Cristofani Is pretreatment hemoglobin level a predictor of response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma? Eur. J. Gynaecol. Oncol. 24 2003 405 410
51. K. Knight, S. Wade, and L. Balducci Prevalence and outcomes of anemia in cancer: a systematic review of the literature Am. J. Med. 116 Suppl 7A 2004 11S 26S
52. R.A. Gatenby, H.B. Kessler, J.S. Rosenblum, L.R. Coia, P.J. Moldofsky, and W.H. Hartz Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 14 1988 831 838
53. G.M. Thomas Raising hemoglobin: an opportunity for increasing survival? Oncology 63 Suppl 2 2002 19 28
54. B.A. Teicher, S.A. Holden, K. Menon, R.E. Hopkins, and M.S. Gawryl Effect of hemoglobin solution on the response of intracranial and subcutaneous 9 L tumors to antitumor alkylating agents Cancer Chemother. Pharmacol. 33 1993 57 62
55. B.A. Teicher, G. Ara, R. Herbst, H. Takeuchi, S. Keyes, and D. Northey PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy In Vivo 11 1997 301 311
56. D.F. Silver, and M.S. Piver Effects of recombinant human erythropoetin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect Gynecol. Oncol. 73 1999 280 284
57. M.J. Keating, T.L. Smith, S. Lerner, S. O'Brien, L.E. Robertson, and H. Kantarjian Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia Leuk. Lymphoma 37 2000 71 85